AKT1 and breast carcinoma: Thus, this study found that orosmucoid 1 upregulation in breast cancer cells increased MMP-2 and MMP-9 expression, activated Akt/ERK signaling pathways, all of which stimulating epirubicin resistance via apoptosis inhibition [105].